CTT Pharmaceutical (CTTH) CEO Buys 1,800 Shares

What Happened

• The CEO of CTT Pharmaceutical Holdings, Inc. (CTTH) reported an open-market purchase of 1,800 shares at $0.06 per share, for a total reported value of approximately $112. The transaction date on the Form 4 is listed as 2026-08-12 and the Form 4 was filed on 2026-08-14. This was a purchase (not a sale), which investors often view as a more informative insider action.

Key Details

• Transaction date: 2026-08-12; Form 4 filed: 2026-08-14
• Type: Open-market purchase (code P)
• Price per share: $0.06; Shares acquired: 1,800; Total reported value: ~$112
• Shares owned after transaction: Not specified in the Form 4
• Footnotes/plan codes: None disclosed (no 10b5-1 plan, tax withholding, or other special notes shown)

Context

• This is a very small-dollar insider purchase; while purchases can signal confidence, the size (~$112) is minimal and may have limited informational value. The filing appears timely (filed within two business days of the transaction date). Retail investors should weigh this alongside broader company fundamentals and other insider activity.